Central Retinal Vein Occlusion Revealing Anti Phospholipid Antibody Syndrome: Case Report


Authors : Dr. Rkia Azahrai; Dr. Manar Achargui; Dr. Fatimazahra Mabrouki; Siham Chariba; Asmaae Maadane; Rachid Sekhsoukh

Volume/Issue : Volume 8 - 2023, Issue 1 - January

Google Scholar : https://bit.ly/3IIfn9N

Scribd : https://bit.ly/40lfQIZ

DOI : https://doi.org/10.5281/zenodo.7597118

Anti-phospholipid antibody syndrome (APAS) is defined by the association of at least one clinical event (vascular occlusion, fetal loss) with the presence of antibodies to phospholipids, and may be isolated or associated with systemic lupus erythematosus. The vascular site of the eye has been described in the literature and may be the main manifestation. We report the case of a 21-year-old woman admitted to the emergency department with a rapid unilateral decrease in visual acuity. Ophthalmological examination revealed an occlusion of the central retinal vein . The diagnosis of SAPL was made during the etiological workup with the presence of anti-cardiolipin antibodies, the patient was put on anti-platelet aggregation treatment. The evolution was marked by the occurrence of a miscarriage, after which the patient was put on anticoagulant treatment. When faced with an occlusion of the central retinal vein or artery in a young subject, in addition to the recommended cardiovascular check-up, a thrombophilia and SAPL check-up is essential in order to avoid a thrombotic recurrence which can be life-threatening if it is a cerebral location.

Keywords : Anti Phospholipid Antibody, Thrombosis, Central Retinal Vein

CALL FOR PAPERS


Paper Submission Last Date
29 - February - 2024

Paper Review Notification
In 1-2 Days

Paper Publishing
In 2-3 Days

Video Explanation for Published paper

Never miss an update from Papermashup

Get notified about the latest tutorials and downloads.

Subscribe by Email

Get alerts directly into your inbox after each post and stay updated.
Subscribe
OR

Subscribe by RSS

Add our RSS to your feedreader to get regular updates from us.
Subscribe